Vanguard Group Inc Apellis Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,809,552 shares of APLS stock, worth $289 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,809,552
Previous 9,505,866
3.19%
Holding current value
$289 Million
Previous $559 Million
32.65%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$483 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$342 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$327 Million5.82% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$171 Million0.01% of portfolio
-
State Street Corp Boston, MA4.15MShares$122 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.24B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...